Dalbavancin for treating prosthetic joint infections caused by Gram-positive bacteria: A proposal for a low dose strategy. A retrospective cohort study

BACKGROUND: Gram-positive bacteria are the leading cause of prosthetic joint infection (PJI). Dalbavancin is a lipoglycopeptide with remarkable pharmacokinetic properties and high bactericidal activity against most Gram-positive bacteria. Although clear evidence regarding its effectiveness in bone a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Rev Esp Quimioter
Asıl Yazarlar: Martín, Luis Buzón, Fernández, María Mora, Perales Ruiz, Jose Manuel, Lafont, Maria Ortega, Paredes, Ledicia Álvarez, Morán Rodríguez, Miguel Ángel, Regueras, María Fernández, Machín Morón, Maria Ángeles, Lobón, Gregoria Mejías
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Sociedad Española de Quimioterapia 2019
Konular:
Original
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913079/
https://ncbi.nlm.nih.gov/pubmed/31642637
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller